Found: 29
Select item for more details and to access through your institution.
Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosis.
- Published in:
- Medical Mycology, 2024, v. 62, n. 2, p. 1, doi. 10.1093/mmy/myae006
- By:
- Publication type:
- Article
AML consolidation therapy: timing matters.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 15, p. 13811, doi. 10.1007/s00432-023-05115-0
- By:
- Publication type:
- Article
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01069-9
- By:
- Publication type:
- Article
Cost comparison of post-remission strategies in younger and older AML patients in France.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00874-y
- By:
- Publication type:
- Article
CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
- Published in:
- Journal of Pathology, 2015, v. 237, n. 1, p. 14, doi. 10.1002/path.4561
- By:
- Publication type:
- Article
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 14, p. 3429, doi. 10.3390/ijms20143429
- By:
- Publication type:
- Article
Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. e50, doi. 10.1111/bjh.18961
- By:
- Publication type:
- Article
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome‐negative B‐precursor acute lymphoblastic leukaemia in first relapse.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 523, doi. 10.1111/bjh.18218
- By:
- Publication type:
- Article
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 10, p. 1870, doi. 10.1002/ajh.27417
- By:
- Publication type:
- Article
Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
- Published in:
- 2017
- By:
- Publication type:
- corrected article
Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 453, doi. 10.3390/cancers14020453
- By:
- Publication type:
- Article
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 629, doi. 10.3390/cancers13040629
- By:
- Publication type:
- Article
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2044, doi. 10.3390/cancers12082044
- By:
- Publication type:
- Article
Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 773, doi. 10.3390/cancers12040773
- By:
- Publication type:
- Article
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 111, doi. 10.1111/ejh.13626
- By:
- Publication type:
- Article
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 859, doi. 10.1111/ejh.13624
- By:
- Publication type:
- Article
Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7003
- By:
- Publication type:
- Article
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7175, doi. 10.1002/cam4.5459
- By:
- Publication type:
- Article
Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 4976, doi. 10.1002/cam4.2371
- By:
- Publication type:
- Article
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00712-7
- By:
- Publication type:
- Article
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 859, doi. 10.1002/ajh.25105
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Les nouvelles options thérapeutiques chez les sujets âgés unfit atteints de leucémie aiguë myéloïde : focus sur les thérapies ciblées.
- Published in:
- Hematologie, 2021, v. 27, p. 13, doi. 10.1684/hma.2021.1630
- By:
- Publication type:
- Article
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 5, p. 824, doi. 10.1002/cncr.30400
- By:
- Publication type:
- Article
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 84, doi. 10.1002/jha2.822
- By:
- Publication type:
- Article